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Telomeres are repetitive DNA sequences and their 
associated proteins at the end of chromosomes. They 
protect against chromosomal degradation and prevent 
chromosomes from fusion, thus play a critical role in 
maintaining genomic stability [1]. Telomere length 
shortens during each round of cell division,  and when it  
 
 













































reaches a critical length, cells stop division and enter 
senescence [2]. Thus, telomere length has been 
considered a marker of biological aging. Shorter 
telomere length has been associated with an increased 
risk of various age-related diseases including 
cardiovascular disease (CVD) [3] and its risk factors, 
e.g., obesity [4], hypertension [5], diabetes [6, 7], and 
dyslipidemia [8]. In a large cohort of American Indians, 























Telomere  length, a marker of biological aging, has been associated with cardiovascular disease  (CVD).  Increased arterial
stiffness,  an  indicator  of  arterial  aging,  predicts  adverse  CVD  outcomes. However,  the  relationship  between  telomere
length  and  arterial  stiffness  is  less well  studied. Here we  examined  the  cross‐sectional  association  between  leukocyte
telomere  length  (LTL) and arterial  stiffness  in 2,165 American  Indians  in  the Strong Heart Family Study  (SHFS). LTL was
measured by qPCR. Arterial stiffness was assessed by stiffness index β. The association between LTL and arterial stiffness
was assessed by generalized estimating equation model, adjusting for sociodemographics (age, sex, education level), study
site,  metabolic  factors  (fasting  glucose,  lipids,  systolic  blood  pressure,  and  kidney  function),  lifestyle  (BMI,  smoking,
drinking,  and physical  activity),  and prevalent CVD. Results  showed  that  longer  LTL was  significantly  associated with  a
decreased arterial stiffness (β=‐0.070, P=0.007). This association did not attenuate after further adjustment for hsCRP (β=‐
0.071,  P=0.005)  or  excluding  participants with  overt  CVD  (β=‐0.068,  P=0.012),  diabetes  (β=‐0.070,  P=0.005),  or  chronic




www.aging‐us.com                      1                                                        AGING (Albany NY) 
we have recently demonstrated prospective associations 
of leukocyte telomere length (LTL) with diabetes [6] 
and carotid atherosclerosis [9] as well as cross-sectional 
association of LTL with obesity [4]. All these 
conditions have been related to arterial aging 
characterized by increased stiffness in the arteries [10]. 
Arterial stiffness refers to the reduced elasticity of an 
artery in response to pressure changes. It increases with 
age [11] and predicts adverse CVD outcomes [12, 13], 
thus representing a key feature of arterial or vascular 
aging [14]. Shorter telomere length has been found in 
vascular smooth muscle cells from aging artery [15]. 
These findings indicate a probable association between 
telomere length and arterial stiffness, however, this 
relationship has been less well studied in human 
populations [16-21]. Among the very few existing 
studies examining the relationship between telomere 
length and arterial stiffness in human populations, 
sample sizes were in general small, and the 
investigations were restricted to European populations 
[18-20]. Moreover, most previous studies failed to 
extensively control for known coronary risk factors. The 
































ed with arterial stiffness in a large cohort of American 
Indians participating in the Strong Heart Family Study 







The current analysis included a total of 2,165 American 
Indian participants (883 men, 1,282 women) with a mean 
age of 41 ± 17 years (aged 14 to 93). The median 
stiffness index β was 3.24 (interquartile range: 2.36-
4.58). Prevalent CVD, diabetes, and chronic kidney 
disease accounted for 5%, 18%, and 6% of the study 
population, respectively. Table 1 shows the baseline 
characteristics of study participants according to LTL 
quartiles. Compared to participants with longer LTL, 
those with shorter LTL had significantly higher body 
mass index, waist circumference, systolic blood pressure, 
and fasting glucose after controlling for age and sex (all 
P < 0.05). No significant difference was detected in other 




































LTL quartiles (T/S ratio) 
P for trend* Q1 
(≤ 0.84) 
Q2 
(0.85 - 0.98) 
Q3 
(0.99 - 1.13) 
Q4 
(> 1.13) 
N 540 542 544 539 - 
Education level, years 12.4±2.3 12.5±2.3 12.2±2.2 12.0±2.2 0.503 
Physical activity, steps/day 5138±3787 5469±3772 6141±3902 6605±4102 0.055 
Body mass index, kg/m2 31.7±6.5 31.6±7.6 31.0±6.9 29.3±7.2 <0.001 
Waist circumference, cm 104.8±17.4 103.3±18.0 101.2±16.5 96.6±16.7 <0.001 
Systolic blood pressure, mmHg 125.5±17.6 124.7±17.2 124.6±17.0 119.3±14.8 0.016 
Diastolic blood pressure, mmHg 76.1±10.5 76.7±11.4 77.3±11.6 74.9±10.9 0.723 
Fasting glucose, mg/dL 114.8±49.6 111.1±45.1 105.8±42.4 99.8±30.8 0.025 
Total cholesterol, mg/dL 187.9±39.6 186.3±37.0 183.9±36.5 174.7±39.0 0.406 
Triglycerides, mg/dL 186.3±269.3 176.7±143.2 166.0±148.6 149.0±191.9 0.354 
LDL-C, mg/dL 101.4±31.7 101.3±30.3 101.4±31.3 94.1±27.8 0.690 
HDL-C, mg/dL 52.1±14.9 51.7±14.7 50.9±15.0 51.8±14.5 0.944 
eGFR, mL/min/1.73 m2 87.0±23.4 93.0±25.4 97.8±25.0 102.0±23.5 0.264 
*Adjust for age and sex using GEE to account for family relatedness. 
LDL‐C:  low  density  lipoprotein  cholesterol;  HDL‐C:  high  density  lipoprotein  cholesterol;  eGFR:  estimated  glomerular 
filtration rate; LTL: leukocyte telomere length. 
  
























Association between LTL and arterial stiffness 
 
Table 2 shows the multivariate-adjusted association 
between LTL and log-transformed stiffness index β 
(log-SI). After adjusting for sociodemographics, study 
site, metabolic factors, lifestyle, and prevalent CVD, 
longer LTL was significantly associated with lower log-
SI (β = -0.070, P = 0.007). Further adjusting for hsCRP 
did not attenuate the association between LTL and log-
SI (β = -0.071, P = 0.005), indicating that the observed 
association between LTL and arterial stiffness may not 
be confounded by inflammation. This association 
remained significant after excluding participants with 
prevalent CVD (β = -0.068, P = 0.012), diabetes (β = -
0.070, P = 0.005), or chronic kidney disease (β = -
0.090, P = 0.001). These results indicated that the 
observed association between LTL and arterial stiffness 
may not be confounded by these chronic conditions. 
 
Results of sensitivity analysis 
 
Additionally adjusting for medications on hypertension, 
diabetes, and hypercholesterolemia did not change the 
association between LTL and arterial stiffness 
(Supplementary Table S1), suggesting that the observed 
association between LTL and arterial stiffness may not 




In a large population of American Indians, we found 
























inversely associated with arterial stiffness, independent 
of known risk factors. This finding provides initial 
evidence that biological aging measured by leukocyte 
telomere length may play a role in arterial aging in 
American Indians. 
 
The inverse association between leukocyte telomere 
length and arterial aging observed in our study is in line 
with previous findings in experimental studies. For 
instance, arterial stiffness was significantly increased in 
klotho-deficient mice as compared to their age-matched 
wild-type littermates [22]. In addition, overexpression 
of the telomeric repeat binding factor 1 (TERF1) gene 
reduced telomere-associated DNA damage foci and pro-
inflammatory cytokine expression in aging endothelial 
cells [23]. As TERF1 gene encodes a protein that 
maintains telomere length,[24] this finding may suggest 
a protective effect of longer telomeres on the 
senescence of endothelial cells in the vascular system. 
 
Several population studies have also reported an inverse 
association between leukocyte telomere length and 
arterial aging [16-20], though mixed results existed 
[21]. For instance, in a recent study including 303 
Russians (mean age 52 years) free of CVD, arterial 
stiffness measured by carotid-femoral pulse wave 
velocity was negatively associated with LTL [18]. This 
association was confirmed in other ethnic groups 
including African-Americans [16] and European 
Caucasians [20]. Moreover, shorter telomere length was 
associated with other measures of vascular/arterial 
aging, e.g., carotid artery intimal medial thickness [25] 
 Table 2. Multivariate‐adjusted association between LTL and log‐transformed stiffness index β in American Indians 
 
Subgroups No. of participants 
Multivariate-adjusted*  Additionally adjusted for hsCRP† 
β (SE) £ P-value  β (SE) £ P-value 
All participants 2165 -0.070 (0.026) 0.007  -0.071 (0.025) 0.005 
No CVD 2062 -0.068 (0.028) 0.014  -0.068 (0.027) 0.012 
No diabetes 1778 -0.069 (0.026) 0.007  -0.070 (0.025) 0.005 
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and endothelial dysfunction [26]. Further, the inverse 
relationship between leukocyte telomere length and 
arterial aging was in agreement with our previous 
studies in American Indians demonstrating that shorter 
telomere length significantly predicted an increased risk 
of carotid atherosclerosis [9] and diabetes [6], both of 
which have been related to arterial stiffness [10]. While 
these results provided evidence for a role of biological 
aging in arterial stiffness, prior investigations were 
mostly of limited sample size and largely conducted in 
populations of European ancestry [18-20]. We are not 
aware of prior studies examining the association 
between LTL and arterial stiffness in American Indians. 
The current study included a large sample of American 
Indians, and our analysis extensively adjusted for 
known risk factors and chronic metabolic conditions. 
Our results suggest that accelerated biological aging 
may underlie the pathogenesis of arterial aging through 
pathways beyond known risk factors. 
 
As medications on hypertension [27], diabetes [28], and 
hypercholesterolemia [29] may exert favorable effects 
on arterial aging, we thus performed additional analysis 
to examine whether the use of these medications may 
influence our results. It shows that additional 
adjustments for medications on hypertension, diabetes, 
and hyperlipidemia did not appreciably attenuate the 
association between LTL and arterial stiffness, 
indicating that the observed association may not be 
confounded by these medications. In addition, as 
previous studies reported that participants with overt 
CVD, diabetes, or chronic kidney disease had increased 
arterial stiffness [12, 13, 30, 31], we conducted separate 
analyses by excluding participants with prevalent CVD, 
diabetes, or chronic kidney disease. Results show that 
the association between telomere length and arterial 
stiffness persisted after excluding participants with 
these chronic conditions. 
 
Inflammation and oxidative stress may underlie the 
observed association between telomere length and 
arterial aging. First, it is known that inflammation and 
oxidative stress are important contributors to 
arterial/vascular aging [32, 33]. Second, inflammation 
or oxidative stress has been shown to accelerate 
telomere shortening in both experimental [34, 35] and 
human studies [36, 37]. Thus, it is possible that the 
observed association between telomere length and 
arterial stiffness may be confounded by inflammation. 
To address this, we conducted additional analysis by 
further adjusting for hsCRP in the GEE model. It 
showed that the association between telomere length 
and arterial stiffness remained unchanged after further 
adjustment for hsCRP, indicating that the observed 
association may not be confounded by inflammation. 
Due to the lack of oxidative stress markers in the SHFS, 
we were unable to examine the influence of oxidative 
stress on our results. We are unaware of previous 
studies examining the relationship between oxidative 
stress, telomere length and arterial/vascular aging. 
 
As far as we are aware, this is the first study to examine 
the association between telomere length and arterial 
stiffness in American Indians. Strengths of this study 
include the high quality telomere data, large sample 
size, and comprehensive adjustments for known risk 
factors, chronic metabolic conditions, as well as 
medications. However, several limitations should also 
be mentioned. First, the cross-sectional nature of our 
analysis precludes us from investigating the potential 
causal role of telomere shortening in arterial stiffness. 
Second, our findings were derived from American 
Indians whose cardiovascular profiles could be different 
from those with other ethnic backgrounds, and thus the 
generalizability of our results to other populations is 
unknown. However, our study population may serve as 
a model for other ethnic groups having high rates of 
diabetes and obesity. Third, leukocyte telomere length 
exhibits a wide range of inter-individual variation, and 
it also varies among cells in the same tissue and among 
chromosomes in the same cell [38]. In the present study, 
we measured telomere length in blood leukocytes but 
not arteries. However, previous studies have 
demonstrated that telomere length in different tissues 
may be highly correlated [39]. 
 
In summary, shorter leukocyte telomere length was 
significantly associated with an increased arterial 
stiffness in American Indians, independent of known 
risk factors. This finding suggests that accelerated 
biological aging may contribute to the pathogenesis of 
arterial aging through biological pathways beyond 
established risk factors. The causal impact of telomere 
shortening on arterial aging warrants further 






The SHFS (2001-ongoing) is a family-based 
longitudinal study designed to identify genetic, 
metabolic, and behavioral factors for CVD, diabetes and 
their risk factors in American Indians in tribes and 
communities residing in Arizona, North/South Dakota, 
and Oklahoma. The study enrolled a total of 3,665 tribal 
members from 94 multigenerational families (14 - 93 
years). All living participants were re-examined about 
4-5 years later. At each visit, participants underwent a 
personal interview and physical examination. 
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Information on sociodemographic factors, disease 
history, medication use, and lifestyle was collected by 
personal interview using standard questionnaires. A 
physical examination was conducted and fasting blood 
samples were collected for laboratory tests, including 
fasting glucose, lipids, and other biomarkers. The SHFS 
protocol was approved by the Institutional Reviews 
Boards from the Indian Health Service and the 
participating institutions and described elsewhere [40]. 
In the current study, 874 participants from one 
community were removed due to withdraw of consent. 
However, the subsample of 2,791 participants did not 
differ significantly from the total sample of 3,665 
participants in the distribution of risk profiles including 
demographic and known clinical factors listed in Table 1. 
After excluding 626 participants with missing data on 
carotid ultrasound examination or telomeres, a total of 
2,165 participants were included in the final data 
analysis. 
 
Leukocyte telomere length measurement 
 
Methods for LTL measurement in the SHFS have been 
described elsewhere [6]. Briefly, genomic DNA from 
peripheral blood was isolated according to standard 
methods. LTL of the derived DNA was measured using 
quantitative PCR through a high-throughput telomere 
length assay system at Dr. Blackburn’s lab at the 
University of California, San Francisco. LTL was 
estimated by the ratio of telomeric product/single copy 
gene (T/S) obtained using quantitative PCR according 
to protocols reported previously [41]. T/S ratio was 
calculated by taking the difference between the mean of 
two T values and two S values attained for each of the 
three replicates. These three T/S ratios were averaged, 
and standard deviation and percent of coefficient 
variation (%CV, standard deviation/mean) were 
calculated. The T/S ratios were normalized to the mean 
of all samples and reported. For quality control, we 
included seven control DNA samples from various 
cancer cell lines in each assay plate. These control 
samples allowed us to create standard curves, which 
were then integrated into a composite standard curve, 
used for T and S concentration calculations. In addition, 
about 20% of the samples selected randomly were 
measured twice. Intra- and inter-assay %CV was 4.6% 




Participants received carotid ultrasonography examina-
tion using Acuson Sequoia machines equipped with 7 
MHz vascular probes on the day of the study visit 
according to a standardized protocol as previously 
described [13]. Arterial diameter data were collected on 
the bilateral common carotid artery during carotid 
ultrasonography examination. In brief, after the 
participants had rested in a supine position for more 
than 20 minutes, two-dimensionally-guided M-mode 
tracings of both the right and left distal common carotid 
artery approximately 1cm proximal to the bulb were 
obtained to measure lumen diameter at end-diastole 
(Dd) and peak-systole (Ds). These data were digitized by 
an analog-to-digital converter, and then sent to the 
Reading Center for further processing. The arterial 
diameter data were estimated as the average over 
several cardiac cycles. The reading of arterial diameter 
data was performed by a highly experienced 
cardiologist who was blinded to the clinical 
characteristics of the participants. 
 
Aortic pressure measurement 
 
Aortic systolic (Ps) and diastolic (Pd) pressures were 
obtained from applanation tonometry performed 
immediately after carotid ultrasonography with the 
position of the subject and ambient environment 
unchanged. The methods for applanation tonometry in 
the Strong Heat Study was reported elsewhere [13]. 
Briefly, applanation tonometry was performed using a 
solid state high-fidelity external Millar transducer. 
Aortic pressures were calculated by the use of the 
SphygmoCor device using a generalized transfer 
function (AtCor Medical, Sydney, Australia) and 
calibration using the brachial mean and diastolic 
pressures obtained immediately before the procedure. 
Orientation and pressure applied to the transducer were 
adjusted to optimize applanation of the artery between 
the transducer and the underlying tissue. 
 
Arterial stiffness estimate 
 
Arterial stiffness was estimated from pressure-diameter 
relations of the left and right common carotid arteries. 
The arterial stiffness index β was calculated according 
to the formula: ln(Ps/Pd)/([Ds-Dd]/Dd) [42], where Ps and 
Pd denote aortic systolic and diastolic pressures, 
respectively, and Ds and Dd denote carotid systole and 
diastole diameters, respectively. The higher SI value of 
bilateral common carotid arteries was used to assess 
arterial stiffness. This approach could reflect more 
accurately the severity of arterial stiffness than one-side 
artery and has been used in previous studies [43]. 
 
Risk factors assessments 
 
Sociodemographics (age, sex, education level) was 
collected by standard questionnaires. Cigarette smoking 
was classified as current smoking, past smoking and 
never smoking. Current smoking was defined as having 
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smoked at least 100 cigarettes in the entire life, having 
smoked cigarettes regularly, and smoking currently. 
Past smoking was defined as having smoked at least 
100 cigarettes in the entire life, having smoked 
cigarettes regularly in the past, but not smoking 
currently. Never smoking was defined as never smoked 
or having smoked fewer than 100 cigarettes in the entire 
life. Alcohol consumption was classified as current 
drinkers, former drinkers and never drinkers as 
previously described [44]. Current drinkers were those 
who had consumed any alcohol during the past year, 
former drinkers had stopped consuming alcohol for ≥ 12 
months, and never drinkers were those who reported 
never drinking alcohol in their life time. Each 
participant was asked to wear a pedometer for seven 
consecutive days and to record the number of the steps 
taken daily in an activity diary. Physical activity was 
assessed by the mean number of steps per day 
calculated by averaging the total number of steps 
recorded in 7 consecutive days. Body weight (kg) and 
height (cm) were measured when participants wore light 
clothes and no shoes by trained staff. Body mass index 
(BMI) was calculated by dividing weight in kilograms 
by the square of height in meters (kg/m2). Waist 
circumference was measured at the level of the 
umbilicus while the participant was in a supine position. 
Blood pressures were measured three times by trained 
staff using a standard mercury sphygmomanometer after 
the participants had been resting for at least 5 minutes 
and the mean of the last two measurements was used in 
statistical analysis. Fasting glucose, serum creatinine, 
and blood lipids, including total cholesterol, 
triglycerides, low density lipoprotein cholesterol (LDL-
C) and high density lipoprotein cholesterol (HDL-C), 
were measured by standard laboratory methods [45]. 
Diabetes was defined as fasting glucose ≥ 126 mg/dL or 
receiving medications on diabetes [46]. Estimated 
glomerular filtration rate (eGFR) was estimated based 
on serum creatinine by using the Modification of Diet in 
Renal Disease Study equation [47]. Chronic kidney 
disease was defined as eGFR < 60 mL/min/1.73 m2 
[48]. Serum high-sensitivity C-reactive protein (hsCRP) 
was measured by an enzyme-linked immunosorbent 
assay (ELISA) developed in-house using purified CRP 
and anti-CRP antibodies from Calbiochem at the 
University of Vermont laboratory [49]. Medications on 
hyper-tension, diabetes, and hypercholesterolemia were 





Baseline characteristics of study participants were 
presented according to LTL quartiles. Arterial stiffness 
index β was log-transformed (i.e., log-SI) to improve 
normality. To examine the association between LTL 
and arterial stiffness, we constructed multivariate 
generalized estimating equation (GEE) model, in which 
log-SI was the dependent variable and LTL was the 
independent variable, adjusting for sociodemographics 
(age, sex, education level), study site, metabolic factors 
(fasting glucose, LDL-C, HDL-C, systolic blood 
pressure, and eGFR), lifestyle (BMI, smoking, drinking, 
and physical activity), and prevalent CVD (y/n). GEE 
model was used here to account for the family 
relatedness among participants. To examine whether 
and to what extent inflammation could potentially 
confound the association between LTL and arterial 
stiffness, we further adjusted for hsCRP in the GEE 
model described above. As prior studies reported that 
arterial stiffness was elevated in patients with prevalent 
CVD, diabetes, and chronic kidney disease [12, 13, 30, 
31], we conducted additional analyses by excluding 
participants with prevalent CVD, diabetes, or chronic 
kidney disease to examine whether these chronic 
conditions influence the relationship between LTL and 
arterial stiffness. A two-tailed P-value < 0.05 was 
considered statistically significant. All statistical 
analyses were conducted using SAS statistical software 




As previous studies reported that some medications on 
hypertension, [27] diabetes,[28] and hypercholestero-
lemia [29] may have favorable effects on arterial 
stiffness, we thus performed sensitivity analysis by 
additionally adjusting for the use of medications (y/n) 
on hypertension, diabetes, and hypercholesterolemia to 
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Subgroups No. of participants 
Multivariate-adjusted*  Additionally adjusted for hsCRP† 
β (SE) P-value  β (SE) P-value 
All participants 2165 -0.069 (0.026) 0.007  -0.070 (0.025) 0.005 
No CVD 2062 -0.067 (0.028) 0.015  -0.066 (0.027) 0.013 
No diabetes 1778 -0.072 (0.028) 0.011  -0.075 (0.029) 0.009 
No chronic kidney disease 2033 -0.088 (0.028) 0.001  -0.089 (0.027) 0.001 
 
LTL: leukocyte telomere length; hsCRP: high‐sensitivity C‐reactive protein. 
*Adjusting  for  sociodemographics  (age,  sex,  education  level),  study  site,  metabolic  factors  (systolic  blood  pressure,  fasting 
glucose,  low‐ and high‐ density  lipoprotein cholesterol, estimated glomerular filtration rate),  lifestyle factors (body mass  index, 
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